Cheung, C. K., Moody, S., Dhaun, N., Griffin, S., Howson, A., Mercer, A., . . . Barratt, J. WCN25-1884 SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL. Elsevier.
Chicago Style (17th ed.) CitationCheung, Chee Kay, et al. WCN25-1884 SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL. Elsevier.
MLA (9th ed.) CitationCheung, Chee Kay, et al. WCN25-1884 SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL. Elsevier.
Warning: These citations may not always be 100% accurate.